Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

[Expression of the activating receptor NKG2D on peripheral blood mononuclear cells in patient with oral squamous cell carcinoma and its clinical significance].

Li C, Shi FQ, Yang D, Wang J, Jian XC, Jiang CH.

Shanghai Kou Qiang Yi Xue. 2012 Aug;21(4):427-31. Chinese.

PMID:
23135119
[PubMed - in process]
2.

Possible association of decreased NKG2D expression levels and suppression of the activity of natural killer cells in patients with colorectal cancer.

Shen Y, Lu C, Tian W, Wang L, Cui B, Jiao Y, Ma C, Ju Y, Zhu L, Shao C, Liu X, Wang J, Zhang B, Lu Z.

Int J Oncol. 2012 Apr;40(4):1285-90. doi: 10.3892/ijo.2011.1315. Epub 2011 Dec 22.

PMID:
22200673
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

[Antitumor immune response of MHC class I chain-related gene A modified oral squamous cell carcinoma vaccine: an experimental study in mice].

Li C, Shi FQ, Wang J, Yang D, Jian XC, Jiang CH.

Shanghai Kou Qiang Yi Xue. 2012 Feb;21(1):1-5. Chinese.

PMID:
22431037
[PubMed - in process]
5.

Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.

Arreygue-Garcia NA, Daneri-Navarro A, del Toro-Arreola A, Cid-Arregui A, Gonzalez-Ramella O, Jave-Suarez LF, Aguilar-Lemarroy A, Troyo-Sanroman R, Bravo-Cuellar A, Delgado-Rizo V, Garcia-Iglesias T, Hernandez-Flores G, Del Toro-Arreola S.

BMC Cancer. 2008 Jan 21;8:16. doi: 10.1186/1471-2407-8-16.

PMID:
18208618
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

[Expression and clinical significance of serum interleukin-27 level in patients with oral squamous cell carcinoma].

Liu Q, Sun ZJ.

Shanghai Kou Qiang Yi Xue. 2013 Apr;22(2):181-3. Chinese.

PMID:
23708032
[PubMed - in process]
7.

Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer.

Shen Y, Wang Q, Qi Y, Cui B, Zhang Z, Su J, Liu X, Lu C, Ye H, Ju Y, Lu Z.

Mol Med Rep. 2014 Aug;10(2):977-82. doi: 10.3892/mmr.2014.2229. Epub 2014 May 13.

PMID:
24819058
[PubMed - in process]
8.

Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients.

Tamaki S, Sanefuzi N, Kawakami M, Aoki K, Imai Y, Yamanaka Y, Yamamoto K, Ishitani A, Hatake K, Kirita T.

Hum Immunol. 2008 Feb;69(2):88-93. doi: 10.1016/j.humimm.2008.01.010. Epub 2008 Feb 22.

PMID:
18361932
[PubMed - indexed for MEDLINE]
9.

[Expression and clinical significance of chemokine receptor 4 in oral squamous cell carcinoma].

Yin D, Gao Z.

Hua Xi Kou Qiang Yi Xue Za Zhi. 2007 Aug;25(4):392-5. Chinese.

PMID:
17896501
[PubMed - in process]
Free Article
10.

Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients.

Zhong LP, Li J, Zhang CP, Zhu HG, Sun J, Zhang ZY.

Arch Oral Biol. 2007 Aug;52(8):740-7. Epub 2007 Feb 28.

PMID:
17331461
[PubMed - indexed for MEDLINE]
11.

[Expression and significance of P75 neurotrophin receptor in oral squamous cell carcinoma].

Wu XY, Tong DD, Zhang FH.

Shanghai Kou Qiang Yi Xue. 2011 Aug;20(4):405-8. Chinese.

PMID:
21909608
[PubMed - in process]
12.

[Expression of NK cells receptor NKG2D from peripheral blood in patients with primary hepatic carcinoma and its clinical significance].

Zeng XH, Sha WH, Li YY, Nie YQ, Li QN, Liang PZ.

Zhonghua Yi Xue Za Zhi. 2009 May 12;89(18):1272-4. Chinese.

PMID:
19595184
[PubMed - indexed for MEDLINE]
13.
14.

[Expression and clinical significance of serum interleukin-8 level in patients with oral squamous cell carcinoma].

Gu WL, Yang JJ.

Shanghai Kou Qiang Yi Xue. 2011 Feb;20(1):78-81. Chinese.

PMID:
21451904
[PubMed - in process]
15.

Augmenting the expression of NKp44 molecule and the natural killer activity in peripheral blood mononuclear cells from patients with malignant colorectal carcinoma.

Sheikhi A, Saadati K, Jafarzadeh A, Karimi H, Mousavinasab N.

Drug Res (Stuttg). 2014 Jun;64(6):281-6. doi: 10.1055/s-0033-1358465. Epub 2013 Oct 23.

PMID:
24154937
[PubMed - in process]
16.

[Correlations between the expression of vascular cell adhesion molecule-1 gene and clinical pathological characteristics and angiogenesis in oral squamous cell carcinoma].

Sun LG, Song YF, Liu L, Yang YC, Wang F, Wang LF.

Shanghai Kou Qiang Yi Xue. 2008 Dec;17(6):569-73. Chinese.

PMID:
19148439
[PubMed - in process]
17.

Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.

Garcia-Iglesias T, Del Toro-Arreola A, Albarran-Somoza B, Del Toro-Arreola S, Sanchez-Hernandez PE, Ramirez-Dueñas MG, Balderas-Peña LM, Bravo-Cuellar A, Ortiz-Lazareno PC, Daneri-Navarro A.

BMC Cancer. 2009 Jun 16;9:186. doi: 10.1186/1471-2407-9-186.

PMID:
19531227
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Hematogenous cytokeratin 20 mRNA detection has prognostic impact in oral squamous cell carcinoma: preliminary results.

Toyoshima T, Vairaktaris E, Nkenke E, Schlegel KA, Neukam FW, Ries J.

Anticancer Res. 2009 Jan;29(1):291-7.

PMID:
19331164
[PubMed - indexed for MEDLINE]
Free Article
19.
20.

[Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].

Ren T, Cai YY, Liang YJ, Jin ML, Guo ZL, Tao MF, He X.

Zhonghua Yi Xue Za Zhi. 2008 Apr 29;88(17):1168-72. Chinese.

PMID:
18844109
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk